Chemoinformaics analysis of 5,6-Decadien-3-yne, 5,7-diethyl-
| Molecular Weight | 190.33 | nRot | 4 |
| Heavy Atom Molecular Weight | 168.154 | nRig | 3 |
| Exact Molecular Weight | 190.172 | nRing | 0 |
| Solubility: LogS | -4.678 | nHRing | 0 |
| Solubility: LogP | 4.893 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 36 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 38.0494 |
| nHD | 0 | BPOL | 22.0706 |
| QED | 0.453 |
| Synth | 3.867 |
| Natural Product Likeliness | 1.538 |
| NR-PPAR-gamma | 0.033 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.175 |
| Pgp-sub | 0.037 |
| HIA | 0.004 |
| CACO-2 | -4.577 |
| MDCK | 0.0000226 |
| BBB | 0.19 |
| PPB | 0.97958 |
| VDSS | 4.073 |
| FU | 0.00992924 |
| CYP1A2-inh | 0.918 |
| CYP1A2-sub | 0.92 |
| CYP2c19-inh | 0.902 |
| CYP2c19-sub | 0.88 |
| CYP2c9-inh | 0.632 |
| CYP2c9-sub | 0.663 |
| CYP2d6-inh | 0.251 |
| CYP2d6-sub | 0.176 |
| CYP3a4-inh | 0.42 |
| CYP3a4-sub | 0.411 |
| CL | 3.561 |
| T12 | 0.67 |
| hERG | 0.033 |
| Ames | 0.009 |
| ROA | 0.047 |
| SkinSen | 0.986 |
| Carcinogencity | 0.143 |
| EI | 0.949 |
| Respiratory | 0.937 |
| NR-Aromatase | 0.549 |
| Antiviral | Yes |
| Prediction | 0.654099 |